Annual Net Income
-$408.17 M
+$162.11 M+28.43%
31 December 2023
Summary:
Biohaven Pharmaceutical Holding annual net profit is currently -$408.17 million, with the most recent change of +$162.11 million (+28.43%) on 31 December 2023. During the last 3 years, it has fallen by -$289.50 million (-243.96%). BHVN annual net income is now -3956.53% below its all-time high of -$10.06 million, reached on 31 December 2015.BHVN Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$160.30 M
+$159.47 M+49.87%
30 September 2024
Summary:
Biohaven Pharmaceutical Holding quarterly net profit is currently -$160.30 million, with the most recent change of +$159.47 million (+49.87%) on 30 September 2024. Over the past year, it has dropped by -$57.73 million (-56.28%). BHVN quarterly net income is now -5332.19% below its all-time high of -$2.95 million, reached on 01 March 2016.BHVN Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$804.34 M
-$57.73 M-7.73%
30 September 2024
Summary:
Biohaven Pharmaceutical Holding TTM net profit is currently -$804.34 million, with the most recent change of -$57.73 million (-7.73%) on 30 September 2024. Over the past year, it has dropped by -$339.82 million (-73.15%). BHVN TTM net income is now -27156.35% below its all-time high of -$2.95 million, reached on 01 March 2016.BHVN TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BHVN Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +28.4% | -56.3% | -73.2% |
| 3 y3 years | -244.0% | -208.9% | -657.0% |
| 5 y5 years | -69.4% | -7.4% | -52.1% |
BHVN Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -244.0% | +28.4% | -208.9% | +49.9% | -657.0% | at low |
| 5 y | 5 years | -244.0% | +28.4% | -208.9% | +49.9% | -657.0% | at low |
| alltime | all time | -3956.5% | +28.4% | -5332.2% | +49.9% | <-9999.0% | at low |
Biohaven Pharmaceutical Holding Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$160.30 M(-49.9%) | -$804.34 M(+7.7%) |
| June 2024 | - | -$319.77 M(+78.1%) | -$746.61 M(+44.4%) |
| Mar 2024 | - | -$179.50 M(+24.0%) | -$517.18 M(+26.7%) |
| Dec 2023 | -$408.17 M(-28.4%) | -$144.76 M(+41.1%) | -$408.17 M(-12.1%) |
| Sept 2023 | - | -$102.57 M(+13.5%) | -$464.52 M(+7.8%) |
| June 2023 | - | -$90.35 M(+28.2%) | -$430.80 M(-20.8%) |
| Mar 2023 | - | -$70.49 M(-64.9%) | -$543.74 M(-4.7%) |
| Dec 2022 | -$570.28 M(+166.7%) | -$201.11 M(+192.1%) | -$570.28 M(+35.4%) |
| Sept 2022 | - | -$68.85 M(-66.1%) | -$421.06 M(+3.6%) |
| June 2022 | - | -$203.29 M(+109.5%) | -$406.57 M(+100.0%) |
| Mar 2022 | - | -$97.03 M(+87.0%) | -$203.28 M(+91.3%) |
| Dec 2021 | -$213.80 M(+80.2%) | - | - |
| Dec 2021 | - | -$51.89 M(-4.6%) | -$106.25 M(-61.0%) |
| Sept 2021 | - | -$54.37 M(-75.0%) | -$272.10 M(-64.5%) |
| Dec 2020 | -$118.67 M(-77.6%) | - | - |
| Dec 2020 | - | -$217.74 M(+11.6%) | -$766.80 M(+9.8%) |
| Sept 2020 | - | -$195.19 M(+7.9%) | -$698.32 M(+14.6%) |
| June 2020 | - | -$180.93 M(+4.6%) | -$609.30 M(-4.7%) |
| Mar 2020 | - | -$172.94 M(+15.9%) | -$639.44 M(+20.9%) |
| Dec 2019 | -$528.80 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | - | -$149.26 M(+40.6%) | -$528.80 M(+21.8%) |
| Sept 2019 | - | -$106.17 M(-49.7%) | -$434.29 M(+11.5%) |
| June 2019 | - | -$211.07 M(+238.8%) | -$389.56 M(+78.9%) |
| Mar 2019 | - | -$62.30 M(+13.8%) | -$217.76 M(-9.6%) |
| Dec 2018 | -$240.92 M(+89.4%) | - | - |
| Dec 2018 | - | -$54.75 M(-10.9%) | -$240.92 M(+13.0%) |
| Sept 2018 | - | -$61.44 M(+56.5%) | -$213.25 M(+9.5%) |
| June 2018 | - | -$39.27 M(-54.1%) | -$194.73 M(+0.4%) |
| Mar 2018 | - | -$85.46 M(+215.6%) | -$193.90 M(+52.4%) |
| Dec 2017 | -$127.19 M(+99.7%) | - | - |
| Dec 2017 | - | -$27.08 M(-36.9%) | -$127.19 M(+1.1%) |
| Sept 2017 | - | -$42.91 M(+11.6%) | -$125.79 M(+13.2%) |
| June 2017 | - | -$38.44 M(+105.0%) | -$111.08 M(+39.8%) |
| Mar 2017 | - | -$18.75 M(-27.0%) | -$79.48 M(+24.8%) |
| Dec 2016 | -$63.68 M(+532.8%) | - | - |
| Dec 2016 | - | -$25.68 M(-9.0%) | -$63.68 M(+67.6%) |
| Sept 2016 | - | -$28.21 M(+312.7%) | -$38.00 M(+288.3%) |
| June 2016 | - | -$6.83 M(+131.6%) | -$9.79 M(+231.6%) |
| Mar 2016 | - | -$2.95 M | -$2.95 M |
| Dec 2015 | -$10.06 M | - | - |
FAQ
- What is Biohaven Pharmaceutical Holding annual net profit?
- What is the all time high annual net income for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding annual net income year-on-year change?
- What is Biohaven Pharmaceutical Holding quarterly net profit?
- What is the all time high quarterly net income for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding quarterly net income year-on-year change?
- What is Biohaven Pharmaceutical Holding TTM net profit?
- What is the all time high TTM net income for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding TTM net income year-on-year change?
What is Biohaven Pharmaceutical Holding annual net profit?
The current annual net income of BHVN is -$408.17 M
What is the all time high annual net income for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high annual net profit is -$10.06 M
What is Biohaven Pharmaceutical Holding annual net income year-on-year change?
Over the past year, BHVN annual net profit has changed by +$162.11 M (+28.43%)
What is Biohaven Pharmaceutical Holding quarterly net profit?
The current quarterly net income of BHVN is -$160.30 M
What is the all time high quarterly net income for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high quarterly net profit is -$2.95 M
What is Biohaven Pharmaceutical Holding quarterly net income year-on-year change?
Over the past year, BHVN quarterly net profit has changed by -$57.73 M (-56.28%)
What is Biohaven Pharmaceutical Holding TTM net profit?
The current TTM net income of BHVN is -$804.34 M
What is the all time high TTM net income for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high TTM net profit is -$2.95 M
What is Biohaven Pharmaceutical Holding TTM net income year-on-year change?
Over the past year, BHVN TTM net profit has changed by -$339.82 M (-73.15%)